thasso: forum

Hypoactive Sexual Desire Disorder (HSDD) (1 reply)

Joseph Gut - thasso
7 years ago
Joseph Gut - thasso 7 years ago

Patient experiences with Flibanserin (Addyi) and similar therapy approaches.

Joseph Gut - thasso
5 years ago
Joseph Gut - thasso 5 years ago

The U.S. Food and Drug Administration just approved Bremelanotide (Vyleesi) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

See here the announcement:

https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-hypoactive-sexual-desire-disorder-premenopausal-women

You need to login to search. Back to thasso patient forum...